ERBB receptor activation is required for profibrotic responses to transforming growth factor β

Cancer Research

Volumn 70, Issue 19, 2010, Pages 7421-7430

  Andrianifahanana, Mahefatiana ^a   Wilkes, Mark C ^a   Repellin, Claire E ^a   Edens, Maryanne ^a   Kottom, Theodore J ^a   Rahimi, Rod A ^a   Leof, Edward B ^a  

^a MAYO CLINIC CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; LAPATINIB; SHORT HAIRPIN RNA; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL SPECIFICITY; CELL SURVIVAL; CELL TRANSFORMATION; ENZYME ACTIVATION; HEPATOMA CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; CELL ADHESION; CELL GROWTH PROCESSES; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; DOGS; FIBROBLASTS; GENE KNOCKOUT TECHNIQUES; HELA CELLS; HUMANS; MICE; ONCOGENE PROTEINS V-ERBB; SIGNAL TRANSDUCTION; SMAD PROTEINS; SWISS 3T3 CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 77957328524     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-0232     Document Type: Article

References (33)

1. Derynck R, Akhurst RJ. Differentiation plasticity regulated by TGF-β family proteins in development and disease. Nat Cell Biol 2007;9:1000-4. (Pubitemid 47338137)
2. Massague J, Blain SW, Lo RS. TGFβ signaling in growth control, cancer, and heritable disorders. Cell 2000;103:295-309.
3. Prud'homme GJ. Pathobiology of transforming growth factor-β in cancer, fibrosis and immunologic disease, and therapeutic considerations. Lab Invest 2007;87:1077-91.
4. Rahimi RA, Leof EB. TGF-β signaling: a tale of two responses. J Cell Biochem 2007;102:593-608.
5. Feng XH, Derynck R. Specificity and versatility in TGF-β signaling through Smads. Annu Rev Cell Dev Biol 2005;21:659-93. (Pubitemid 41740650)
6. Heldin CH, Landstrom M, Moustakas A. Mechanism of TGF-β signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr Opin Cell Biol 2009;21:166-76.
7. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen 2008;16:585-601.
8. de Caestecker M. The transforming growth factor-β superfamily of receptors. Cytokine Growth Factor Rev 2004;15:1-11. (Pubitemid 38121286)
9. Ross S, Hill CS. How the Smads regulate transcription. Int J Biochem Cell Biol 2008;40:383-408.
10. Shi Y, Massague J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 2003;113:685-700. (Pubitemid 36724933)
11. Zhang YE. Non-Smad pathways in TGF-β signaling. Cell Res 2009;19:128-39.
12. Fuller SJ, Sivarajah K, Sugden PH. ErbB receptors, their ligands, and the consequences of their activation and inhibition in the myocardium. J Mol Cell Cardiol 2008;44:831-54.
13. Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2001;2:127-37.
14. Harris RC, Chung E, Coffey RJ. EGF receptor ligands. Exp Cell Res 2003;284:2-13.
15. Ishii Y, Fujimoto S, Fukuda T. Gefitinib prevents bleomycin-induced lung fibrosis in mice. Am J Respir Crit Care Med 2006;174:550-6. (Pubitemid 44330548)
16. Rice AB, Moomaw CR, Morgan DL, Bonner JC. Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats. Am J Pathol 1999;155:213-21.
17. Hardie WD, Le Cras TD, Jiang K, Tichelaar JW, Azhar M, Korfhagen TR. Conditional expression of transforming growth factor-α in adult mouse lung causes pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2004;286:L741-9.
18. Hardie WD, Davidson C, Ikegami M, et al. EGF receptor tyrosine kinase inhibitors diminish transforming growth factor-α-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2008;294:L1217-25.
19. Vinals F, Pouyssegur J. Transforming growth factor-β1 (TGF-β1) promotes endothelial cell survival during in vitro angiogenesis via an autocrine mechanism implicating TGF-α signaling. Mol Cell Biol 2001;21:7218-30.
20. Caja L, Ortiz C, Bertran E, et al. Differential intracellular signalling induced by TGF-β in rat adult hepatocytes and hepatoma cells: implications in liver carcinogenesis. Cell Signal 2007;19:683-94.
21. Wilkes MC, Murphy SJ, Garamszegi N, Leof EB. Cell type-specific activation of PAK2 by transforming growth factor-β independent of Smad2 and Smad3. Mol Cell Biol 2003;23:8878-89.
22. Rahimi RA, Andrianifahanana M, Wilkes MC, et al. Distinct roles for mammalian target of rapamycin complexes in the fibroblast response to transforming growth factor-β. Cancer Res 2009;69:84-93.
23. Daniels CE, Wilkes MC, Edens M, et al. Imatinib mesylate inhibits the profibrogenic activity of TGF-β and prevents bleomycin-mediated lung fibrosis. J Clin Invest 2004;114:1308-16.
24. Wilkes MC, Leof EB. Transforming growth factor-β activation of c- Abl is independent of receptor internalization and regulated by phosphatidylinositol 3-kinase and PAK2 in mesenchymal cultures. J Biol Chem 2006;281:27846-54.
25. Wilkes MC, Mitchell H, Penheiter SG, et al. Transforming growth factor- β activation of phosphatidylinositol 3-kinase is independent of Smad2 and Smad3 and regulates fibroblast responses via p21- activated kinase-2. Cancer Res 2005;65:10431-40.
26. Henson ES, Gibson SB. Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy. Cell Signal 2006;18:2089-97.
27. Thomson S, Petti F, Sujka-Kwok I, Epstein D, Haley JD. Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy. Clin Exp Metastasis 2008;25:843-54.
28. Shipley GD, Childs CB, Volkenant ME, Moses HL. Differential effects of epidermal growth factor, transforming growth factor, and insulin on DNA and protein synthesis and morphology in serum-free cultures of AKR-2B cells. Cancer Res 1984;44:710-6.
29. Wynn TA. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 2007;117:524-9.
30. Schneider MR, Wolf E. The epidermal growth factor receptor ligands at a glance. J Cell Physiol 2009;218:460-6.
31. Sahin U, Weskamp G, Kelly K, et al. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol 2004;164:769-79.
32. Wang SE, Xiang B, Guix M, et al. Transforming growth factor-β engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab. Mol Cell Biol 2008;28:5605-20.
33. Bruna A, Darken RS, Rojo F, et al. High TGFβ-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Cancer Cell 2007;11:147-60.